1. Market Research
  2. > Healthcare
  3. > Medical Device Market Trends
  4. > Medical Devices: Technologies and Global Markets

Medical Devices: Technologies and Global Markets

  • September 2014
  • -
  • BCC Research
  • -
  • 309 pages

This BCC Research report discusses the medical device technologies in terms of market share of major players, market growth and size, and opportunities for different devices and regions. It includes forecasts for market trends and revenue through 2018. Patent analysis in the report focuses on technological trends in recent years in geographies such as the U.S., Europe and Japan.

Use this report to:
- Define and discuss the global medical device technologies market.
- Analyze market structure, including segments and subsegments.
- Study various submarkets with respect to growth drivers and inhibitors of the medical device technologies market.
- Identify market trends, issues and factors impacting medical device technologies.

Highlights
- BCC Research estimates the global market for medical device technologies as $390.3 billion in 2012. This indication has reached $411.8 billion in 2013 and is expected to reach $538.7 billion in 2018, registering a compound annual growth (CAGR) of 5.5% over the next five years.
- North America as a segment will grow from $187.6 billion in 2013 to nearly $225.4 billion by 2018 at a 3.7% CAGR for the period 2013-2018.
- Asia is the largest segment of the global market for medical device technologies and it has reached $7.1 billion in 2013 and is expected to reach $10.8 billion by 2018, increasing at a CAGR of 8.5% from 2013 through 2018.

INTRODUCTION
This report discusses the medical device technologies in terms of market share of major players, market growth and size, and opportunities for different devices and regions. The report includes forecasts for market trends and revenue through 2018. Major players, innovative products and technologies, trends and market dynamics, competitive intelligence, and geographic trends are well researched and analyzed in the report.

STUDY GOALS AND OBJECTIVES
The goals and objectives of the study include the following:
- Define and discuss the global medical device technologies market.
- Analyze market structure, including segments and subsegments.
- Estimate market revenues of the global medical device technologies industry by segment, geography and products.
- Identify market trends, issues and factors impacting medical device technologies.
- Study various submarkets with respect to growth drivers and inhibitors of the medical device technologies market.
- Explain opportunities in the medical device technologies market with respect to geography and products.
- Profile major players and analyze their market share, core competencies and strategies in the medical device technologies market.
- Track alliances, joint ventures, mergers and acquisitions, new product developments and research and development in the global medical device technologies market.

MARKET DESCRIPTION
A medical device is an instrument, apparatus, implant, in vitro reagent or similar device used to diagnose, prevent or treat disease or other conditions. There are several medical device technologies that enhance the functions of medical devices, including highly sophisticated scanners and technologically complicated implantable products such as the artificial cochlear devices as well as the most basic laboratory equipment. According to estimates, there are over 500,000 medical technologies currently available in about 20,000 generic groups. According to World Health Organization (WHO), there are an estimated 1.5 million different medical devices, in over more than 10 000 types of generic device groups available worldwide. The Global Medical Devices Nomenclature (GMDN) Agency has put classified these into 16 categories of products.

The primary aim of any medical technology is to improve medical care, making it easier to improve the overall health of users or patients. With life spans having increased over the last few decades, the importance of better care and improved quality of life has become paramount.

SCOPE OF THE REPORT
This research report incorporates an in-depth analysis of the medical device technologies market, including market estimations and trends through 2018. Major players, competitive intelligence, innovative technologies, market dynamics and geographic opportunities are discussed in detail in the report. The report also examines recent developments and product portfolios of the major players along with their market shares. Patent analysis in the report focuses on technological trends in recent years in geographies such as the U.S., Europe and Japan. The report presents a market analysis and estimates the compound annual growth rate (CAGR) for medical device
technologies.

The scope of the report extends to only those medical device technologies that generate the most revenue globally. However, we have excluded dental device technologies as some imaging devices used in dentistry overlap with other devices already covered under the imaging device technologies segments.

INTENDED AUDIENCE
Individuals and groups who would benefit from the content of this report include:
- Medical device manufacturers and new entrants.
- Equipment distributors, hospitals and other healthcare service providers.
- Various life sciences companies.
- Research institutes, associations and academicians.

Table Of Contents

Medical Devices: Technologies and Global Markets
TABLE OF CONTENTS
CHAPTER 1 INTRODUCTION 2
STUDY GOALS AND OBJECTIVES 2
MARKET DESCRIPTION 2
SCOPE OF THE REPORT 3
INTENDED AUDIENCE 3
RESEARCH METHODOLOGY 3
ANALYST'S CREDENTIALS 3
RELATED BCC RESEARCH REPORTS 4
BCC RESEARCH WEBSITE 4
DISCLAIMER 5
CHAPTER 2 EXECUTIVE SUMMARY 7
SUMMARY TABLE GLOBAL MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY
REGION, THROUGH 2018 ($ MILLIONS) 7
SUMMARY FIGURE GLOBAL MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY
REGION, 2012-2018 ($ MILLIONS) 7
CHAPTER 3 MARKET OVERVIEW 10
INNOVATIONS IN THE MEDICAL DEVICE TECHNOLOGIES INDUSTRY 11
CURRENT TRENDS IN THE MEDICAL DEVICE TECHNOLOGIES INDUSTRY 11
DEFINITION, EVOLUTION AND TYPES OF MEDICAL TECHNOLOGIES 12
Definition 13
Evolution 13
Types 16
REGULATIONS AND LEGISLATIONS 17
Europe 17
ROHS II 18
U.S. 19
China 21
Japan 22
India 23
Others 24
Indonesia 24
Korea 24
Malaysia 25
The Philippines 25
Singapore 26
Taiwan 27
Australia 27
Hong Kong 28
Vietnam 28
MARKET DYNAMICS 28
Drivers 28
Aging Global Population 28
FIGURE 1 PERCENTAGE OF THE POPULATION OVER 60 YEARS OF AGE, BY REGION,
2013 (%) 28
Increase in Lifestyle and Chronic Diseases 30
FIGURE 2 PROJECTED GROWTH OF DIABETES ACROSS THE TOTAL GLOBAL
POPULATION, 2010 AND 2030 (%) 30
Molecular Medicine and Minimally Invasive Techniques 31
Other Drivers 31
Restraints 32
Opportunities 33
STRATEGIES 33
DISTRIBUTION NETWORK 34
Asia 34
United States 35
Europe 35
India 36
China 37
Others 38
Japan 38
Korea 39
TRENDS 39
China 39
Europe 40
NEW PRODUCTS AND TECHNOLOGIES 40
NEW MATERIALS 41
REFURBISHED/REPLACEMENT MARKET 41
MERGERS AND ACQUISITIONS 43
RECOMMENDATIONS 44
CHAPTER 4 GLOBAL MEDICAL DEVICE TECHNOLOGIES MARKET 47
OVERVIEW 47
TABLE 1 GLOBAL MARKET FOR MEDICAL DEVICE TECHNOLOGIES, BY SEGMENT,
THROUGH 2018 ($ MILLIONS) 47
IMAGING DEVICES 47
TABLE 2 GLOBAL MARKET FOR IMAGING DEVICE TECHNOLOGIES BY SEGMENT,
THROUGH 2018 ($ MILLIONS) 48
MARKET DYNAMICS 48
Increased Life Expectancy 49
Growing Incidence of Diseases 49
Improvement in Medical Device Technologies 49
Legislative Amendments and Other Initiatives 49
Resistance to New Technology-based Systems Due to High Costs 50
Excise Duties Levied Under the Patient Protection and Affordable
Care Act (PPACA) 50
Large Population Base in Emerging Economies 50
Increasing Government Spending on Healthcare and Healthcare
Infrastructure 50
TABLE 3 GLOBAL MARKET FOR IMAGING DEVICE TECHNOLOGIES BY REGION,
THROUGH 2018 ($ MILLIONS) 51
MAGNETIC IMAGING RESONANCE 51
Market Dynamics 52
FIGURE 3 GLOBAL NUMBER OF PATIENTS WITH CHRONIC DISEASES, 2005-2030
(MILLIONS) 52
TABLE 4 GLOBAL MARKET FOR MRI TECHNOLOGY BY REGION,THROUGH 2018 ($
MILLIONS) 53
Innovation and New Products 54
GE Healthcare 54
Toshiba 55
Siemens 55
Hitachi 56
Philips 56
Trends 56
FIGURE 4 MARKET SHARE OF KEY COMPANIES IN THE MRI TECHNOLOGIES MARKET,
2012 (%) 57
ULTRASOUND TECHNOLOGIES MARKET 58
Market Dynamics 58
FIGURE 5 TOP 10 COUNTRIES WITH THE HIGHEST PERCENTAGE PEOPLE AGED 60
AND OVER, 2011 (%) 58
FIGURE 6 TOP 10 COUNTRIES WITH THE HIGHEST EXPECTED PERCENTAGE OF
PEOPLE AGED 60 AND OVER, 2050 (%) 59
New Product Innovations 61
Market Trends 62
TABLE 5 GLOBAL MARKET FOR ULTRASOUND TECHNOLOGIES, BY REGION,
THROUGH 2018 ($ MILLIONS) 63
FIGURE 7 COMPANY MARKET SHARES OF ULTRASOUND TECHNOLOGIES, 2012 (%) 64
LASER IMAGING MARKET 65
TABLE 6 GLOBAL MARKET FOR LASER IMAGING DEVICES TECHNOLOGIES, BY
REGION, THROUGH 2018 ($ MILLIONS) 65
Market Dynamics 65
FIGURE 8 GLOBAL PREVALENCE OF ALZHEIMER'S DISEASE, 2010-2050 (MILLIONS) 66
New Product Innovations 67
Market Trends 68
FIGURE 9 COMPANY SHARES FOR LASER IMAGING MARKET, 2012 (%) 69
INTERVENTIONAL RADIOLOGY MARKET 69
TABLE 7 GLOBAL MARKET FOR INTERVENTIONAL RADIOLOGY DEVICES
TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS) 70
Market Dynamics 70
FIGURE 10 NUMBER OF ANGIOPLASTY PROCEDURES CONDUCTED GLOBALLY,
2009-2012 (NO. OF PROCEDURES) 71
FIGURE 11 NUMBER OF STENTS USED IN CORONARY PROCEDURES GLOBALLY,
2009-2012 (NO. OF STENTS) 72
Innovation and New Products 73
Market Trends 73
X-RAY 74
TABLE 8 GLOBAL MARKET FOR X-RAY DEVICE TECHNOLOGIES BY REGION,
THROUGH 2018 ($ MILLIONS) 74
Market dynamics 75
FIGURE 12 PACS PROCESS OF OBTAINING IMAGES 75
FIGURE 13 GLOBAL PERCENTAGE OF POPULATION BY AGE GROUP, 2000-2050 (%) 76
TABLE 9 TARGET DISEASE STATISTICS 77
Innovation and New products 77
Market Trends 78
FIGURE 14 X-RAY MARKET COMPANY SHARES, 2012 (%) 79
COMPUTER TOMOGRAPHY 80
TABLE 10 GLOBAL MARKET FOR COMPUTER TOMOGRAPHY TECHNOLOGIES BY
REGION, THROUGH 2018 ($ MILLIONS) 81
Market Dynamics 81
FIGURE 15 INSTANCES OF CORONARY HEART DISEASE IN SELECTED COUNTRIES,
2012 (%) 82
Innovation and New Products 83
GE Healthcare 83
Phillips 84
NUCLEAR MEDICINE/ POSITRON EMISSION TOMOGRAPHY (PET) 84
TABLE 11 GLOBAL MARKET FOR NUCLEAR MEDICINE/PET TECHNOLOGIES BY
REGION, THROUGH 2018 ($ MILLIONS) 85
Market dynamics 85
FIGURE 16 PERCENTAGE OF GLOBAL CARDIOVASCULAR MORTALITY BY INCOME
LEVEL, 2011 (%) 85
Innovation and New products 87
Market Trends 88
TABLE 12 REIMBURSEMENT POLICIES BY THE CENTERS FOR MEDICARE AND
MEDICAID SERVICES IN THE U.S. 90
Market share of key players 91
POINT OF CARE TECHNOLOGIES 91
TABLE 13 GLOBAL MARKET FOR POINT OF CARE TECHNOLOGIES BY REGION,
THROUGH 2018 ($ MILLIONS) 91
Market Dynamics 91
Innovation and New Products 92
Market Trends 93
Market Share of Key Players 93
IN VITRO DIAGNOSTIC DEVICES 93
TABLE 14 GLOBAL MARKET FOR IN VITRO DIAGNOSTIC TECHNOLOGIES BY REGION,
THROUGH 2018 ($ MILLIONS) 94
MARKET DYNAMICS 95
FIGURE 17 HEALTHCARE EXPENDITURES IN THE U.S., CHINA AND INDIA,
2009-2011 ($ BILLIONS) 95
Overall in Vitro Diagnostics Market Share 98
FIGURE 18 IN VITRO DIAGNOSTICS MARKET COMPANY MARKET SHARES, 2012 (%) 98
Professional In Vitro Diagnostics Market Share 100
FIGURE 19 PROFESSIONAL DIAGNOSTICS MARKET COMPANY MARKET SHARES,
2012 (%) 100
Types of In Vitro Diagnosis 101
Immunoassays 101
Diabetes Testing 101
Blood Testing/ Hematology 102
Molecular Diagnosis 102
TABLE 15 GLOBAL MARKET FOR IN VITRO DIAGNOSTICS TECHNOLOGIES BY
SEGMENTS, THROUGH 2018 ($ MILLIONS) 102
REGULATIONS 103
IVD MARKET BY GEOGRAPHY 104
IMMUNOCHEMISTRY 105
TABLE 16 GLOBAL MARKET FOR IMMUNOCHEMISTRY TECHNOLOGIES BY
REGION,THROUGH 2018 ($ MILLIONS) 105
MARKET DYNAMICS 106
FIGURE 20 INSTANCES OF CARDIOVASCULAR DISEASE IN SELECTED REGIONS,
2012 (%) 107
FIGURE 21 NEW GLOBAL HIV INFECTIONS BY REGION, 2012 (NO. OF INFECTIONS) 108
INNOVATION AND NEW PRODUCTS 109
TRENDS 110
MARKET SHARE OF KEY PLAYERS 110
FIGURE 22 IMMUNOASSAY MARKET SHARES FOR INFECTIOUS DISEASES
(EXCLUDING HEPATITIS AND RETROVIRUS), 2012 (%) 110
FIGURE 23 IMMUNOASSAY MARKET SHARES FOR HEPATITIS AND RETROVIRUS,
2012 (%) 111
FIGURE 24 IMMUNOASSAY MARKET SHARES FOR ONCOLOGY AND
ENDOCRINOLOGY, 2012 (%) 113
FIGURE 25 IMMUNOASSAY MARKET SHARES FOR NUCLEIC ACID TESTING, 2012 (%) 114
TABLE 17 GLOBAL MARKET FOR CLINICAL CHEMISTRY TECHNOLOGIES BY REGION,
THROUGH 2018 ($ MILLIONS) 115
POINT-OF-CARE DIAGNOSTICS MARKET 115
TABLE 18 POINT-OF-CARE DIAGNOSTICS TESTS AND MANUFACTURERS 116
TABLE 19 INCIDENCE OF DIABETES FOR THE TOP 10 COUNTRIES, 2013
(THOUSANDS) 117
FIGURE 26 REGIONAL PREVALENCE OF DIABETES BY AGE GROUPS, 2013
(THOUSANDS) 118
FIGURE 27 SHIFT OF USAGE OF POINT OF CARE DIAGNOSTIC SOLUTIONS 118
TABLE 20 GLOBAL MARKET FOR POINT-OF-CARE TESTING TECHNOLOGIES BY
REGION, THROUGH 2018 ($ MILLIONS) 119
INNOVATION AND NEW PRODUCTS 120
TRENDS 120
FIGURE 28 U.S. HOSPITAL HEALTHCARE SPENDING, 2010-2012 ($ BILLIONS) 120
TABLE 21 POINT-OF-CARE DIAGNOSTIC SOLUTIONS ACROSS VARIOUS PRODUCT
SEGMENTS 121
COMPETITIVE LANDSCAPE 121
FIGURE 29 POINT-OF-CARE DIAGNOSTICS COMPANY MARKET SHARES, 2012 (%) 122
MOLECULAR DIAGNOSTICS 123
TABLE 22 GLOBAL MARKET FOR MOLECULAR DIAGNOSTICS TECHNOLOGIES BY
REGION, THROUGH 2018 ($ MILLIONS) 123
GROWING GLOBAL PREVALENCE OF HOSPITAL-ACQUIRED AND HPV
INFECTIONS 123
FIGURE 30 APPLICATION PERCENTAGE OF MOLECULAR DIAGNOSTICS IN
INFECTIOUS DISEASE SEGMENTS (%) 123
PHARMACOGENOMICS 124
MARKET TRENDS 125
U.S. 125
China 125
India 126
Overall Market Trends 126
COMPETITIVE LANDSCAPE 126
FIGURE 31 MOLECULAR DIAGNOSTICS COMPANY MARKET SHARES, 2012 (%) 126
BLOOD TESTING (HEMATOLOGY/ HEMOSTASIS) 127
TABLE 23 GLOBAL MARKET FOR HEMATOLOGY TECHNOLOGIES BY REGION,
THROUGH 2018 ($ MILLIONS) 129
MARKET TRENDS 129
U.S. 129
China 129
COMPETITIVE LANDSCAPE 130
CARDIOVASCULAR DEVICE MARKET 130
TABLE 24 GLOBAL MARKET FOR CARDIOVASCULAR DEVICE TECHNOLOGIES BY
SEGMENT, THROUGH 2018 ($ MILLIONS) 130
TYPES OF CARDIOVASCULAR DISEASES 131
Cardiac Arrhythmia 131
TABLE 25 ABLATION TYPES AND THEIR MECHANISMS 132
Coronary Blockages 132
TABLE 26 GLOBAL MARKET FOR CARDIOVASCULAR DEVICE TECHNOLOGIES BY
REGION, THROUGH 2018 ($ MILLIONS) 133
MARKET DYNAMICS 133
FIGURE 32 GLOBAL POPULATION BY AGE GROUP, 2000 AND 2050 (%) 134
INTERVENTIONAL CARDIOLOGY DEVICES 135
Stents 135
FIGURE 33 EVOLUTION OF CORONARY STENTS 135
TABLE 27 INCIDENCE PERCENTAGE OF RESTENOSIS BY STENT TYPE 136
TABLE 28 DRUG ELUTING STENT PRODUCTS AND MANUFACTURERS 136
TABLE 29 BIO-ABSORBABLE STENT PRODUCTS AND MANUFACTURERS 137
PTCA Balloons 137
TABLE 30 COMPARATIVE ANALYSIS OF STENTS BY BALLOON PLATFORM 138
PTCA Guidewires 138
PTCA Guiding Catheters 139
Angiography Catheters 139
Balloon Inflation Devices 139
TABLE 31 PRODUCTS AND MANUFACTURERS 140
Intravascular Ultrasound 140
Cardiovascular Device Market Trends 141
REGULATIONS 142
CARDIAC RHYTHM MANAGEMENT MARKET 142
TABLE 32 GLOBAL MARKET FOR CARDIAC RHYTHM MANAGEMENT TECHNOLOGIES
BY REGION, THROUGH 2018 ($ MILLIONS) 143
MARKET DYNAMICS 143
FIGURE 34 GLOBAL POPULATION BASE TO 65 YEARS AND ABOVE, 2000-2050 (%) 143
MARKET TRENDS 145
Pharmacological Treatment 145
TABLE 33 ANTI- ARRHYTHMIC DRUG TYPES AND CLINICAL USAGE 145
TABLE 34 ANTI-ARRHYTHMIC DRUGS: CLASSIFICATION AND CLINICAL USAGE 146
Non-pharmacological Treatment 148
Maze Surgery Procedures 149
Electric Cardioversion Procedures 149
Global Market Trends 150
COMPETITIVE RIVALRY 151
CARDIAC CATHETERIZATION TECHNOLOGIES 152
TABLE 35 GLOBAL MARKET FOR CARDIAC CATHETERIZATION TECHNOLOGIES BY
REGION, THROUGH 2018 ($ MILLIONS) 152
MARKET DYNAMICS 153
INNOVATION AND NEW PRODUCTS 155
ORTHOPEDIC AND SPINAL TECHNOLOGIES 155
TABLE 36 GLOBAL MARKET FOR ORTHOPEDIC AND SPINAL TECHNOLOGIES, BY
SEGMENT, THROUGH 2018 ($ MILLIONS) 156
MARKET DYNAMICS 156
GEOGRAPHY 156
TABLE 37 GLOBAL MARKET FOR ORTHOPEDIC AND SPINE TECHNOLOGIES, BY
REGION, THROUGH 2018 ($ MILLIONS) 157
REGULATIONS 157
RECONSTRUCTIVE IMPLANTS 158
TABLE 38 GLOBAL MARKET FOR RECONSTRUCTIVE IMPLANT TECHNOLOGIES BY
REGION, THROUGH 2018 ($ MILLIONS) 158
MARKET DYNAMICS 159
FIGURE 35 NUMBER OF OSTEOPOROTIC HIP FRACTURES BY REGION, 1990-2050
(THOUSANDS) 159
INNOVATION AND NEW PRODUCTS 161
TRENDS 162
MARKET SHARE 163
FIGURE 36 RECONSTRUCTIVE IMPLANT TECHNOLOGIES COMPANY MARKET
SHARES, 2012 (%) 163
SPINAL IMPLANTS 164
TABLE 39 GLOBAL MARKET FOR SPINE DEVICE TECHNOLOGIES BY REGION,
THROUGH 2018 ($ MILLIONS) 165
Market Dynamics 165
Market Trends 166
TABLE 40 FDA AND CE APPROVALS OF SPINAL CORD STIMULATION DEVICES 168
Innovation and New products 168
Market Share Analysis 169
FIGURE 37 SPINAL IMPLANT COMPANY MARKET SHARES, 2012 (%) 169
TRAUMA FIXATION DEVICE TECHNOLOGIES MARKET 169
TABLE 41 GLOBAL MARKET FOR TRAUMA FIXATION DEVICE TECHNOLOGIES BY
REGION, THROUGH 2018 ($ MILLIONS) 170
Market Dynamics 171
FIGURE 38 TRAUMA DEVICE FIXATION COMPANY MARKET SHARES, 2012 (%) 171
Orthopedic Robotic Systems 172
TABLE 42 GLOBAL MARKET FOR ROBOTIC SYSTEM TECHNOLOGIES BY REGION,
THROUGH 2018 ($ MILLIONS) 173
Major Orthopedic Robotic Systems 173
MAKO RIO Surgical System 173
Stanmore Sculptor Robotic Guidance Arm (RGA) 173
NavioPFS Surgical System 174
iBlock surgical system 174
ROBODOC Surgical System 175
UROLOGY DEVICE MARKET 175
TABLE 43 GLOBAL MARKET FOR UROLOGY AND RENAL DEVICE TECHNOLOGIES BY
SEGMENT, THROUGH 2018 ($ MILLIONS) 176
MARKET DYNAMICS 176
TABLE 44 GLOBAL MARKET FOR UROLOGY AND RENAL DEVICES TECHNOLOGIES
BY REGION, THROUGH 2018 ($ MILLIONS) 177
MEDICAL LASER SYSTEMS FOR UROLOGY 177
TABLE 45 GLOBAL MARKET FOR LITHOTRIPTER DEVICES BY REGION, THROUGH
2018 ($ MILLIONS) 178
GEOGRAPHY 178
FIGURE 39 GLOBAL PREVALENCE OF KIDNEY DISEASE, 2012 (%) 178
REGULATIONS 179
INCONTINENCE DEVICES 180
Market Dynamics 180
FIGURE 40 LIFE EXPECTANCY AT BIRTH FOR SELECTED COUNTRIES, 2012 (YEARS) 180
TRENDS 181
TABLE 46 GLOBAL MARKET FOR INCONTINENCE DEVICE TECHNOLOGIES BY
REGION, THROUGH 2018 ($ MILLIONS) 182
FIGURE 41 GROWTH (MILLION) IN THE GLOBAL POPULATION BASE OVER THE AGE
OF 60 YEARS, 2010 TO 2017 (%) 182
INNOVATION AND NEW PRODUCTS 183
MARKET SHARES 183
Ostomy Care Device Market 183
FIGURE 42 OSTOMY CARE DEVICE COMPANY MARKET SHARES, 2012 (%) 184
Incontinence Care Device Market 184
FIGURE 43 INCONTINENCE CARE DEVICE COMPANY MARKET SHARES, 2012 (%) 184
RENAL DIALYSIS DEVICE MARKET 185
TABLE 47 GLOBAL MARKET FOR RENAL DIALYSIS DEVICE TECHNOLOGIES BY
REGION, THROUGH 2018 ($ MILLIONS) 186
FIGURE 44 RENAL DIALYSIS DEVICE COMPANY MARKET SHARES, 2012 (%) 186
ENDOSCOPY DEVICES 187
TABLE 48 GLOBAL MARKET FOR ENDOSCOPY DEVICE TECHNOLOGIES BY SEGMENT,
THROUGH 2018 ($ MILLIONS) 187
TYPES 187
TABLE 49 GLOBAL MARKET FOR ENDOSCOPY DEVICE TECHNOLOGIES BY REGION,
THROUGH 2018 ($ MILLIONS) 188
MARKET DYNAMICS 189
FIGURE 45 GLOBAL PREVALENCE OF COLON CANCER BY AGE 189
RIGID ENDOSCOPES 190
TABLE 50 GLOBAL MARKET FOR RIGID ENDOSCOPIC DEVICES TECHNOLOGIES BY
REGION, THROUGH 2018 ($ MILLIONS) 191
Market Dynamics 191
FLEXIBLE ENDOSCOPES 192
TABLE 51 GLOBAL MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY REGION,
THROUGH 2018 ($ MILLIONS) 192
Market Dynamics 193
INNOVATION AND NEW PRODUCTS 193
DRUG DELIVERY DEVICES 194
TABLE 52 GLOBAL MARKET FOR DRUG DELIVERY DEVICE TECHNOLOGIES BY
SEGMENT, THROUGH 2018 ($ MILLIONS) 194
TABLE 53 GLOBAL MARKET FOR DRUG DELIVERY DEVICE TECHNOLOGIES BY
REGION, THROUGH 2018 ($ MILLIONS) 195
MARKET DYNAMICS 195
Increasing Prevalence of Cardiovascular Disease 195
Increasing Global Prevalence of Prostate Cancer 195
Emergence of New Disease Applications (Cervical Cancer, Breast
Cancer) 196
Growing Global Elderly Population Base 196
Rising Prevalence of Diabetes and Diabetic Retinopathy 196
Growing Prevalence of Unwanted Pregnancies 196
Government and NGO Initiatives to Promote Contraceptive Products 196
Introduction of New and Advanced Implantable Drug Delivery
Devices 197
Introduction of Biodegradable Technology Products 197
Product Recalls, Lawsuits and the Introduction of Internal Product
Substitutes 197
"Stringent FDA and CE Approval Norms 198
INFUSION SYSTEMS 198
TABLE 54 GLOBAL MARKET FOR INFUSION SYSTEM AND INJECTABLE DEVICE
TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS) 199
Market Dynamics 199
Rising Global Prevalence of Colorectal Cancer 199
High Prevalence of Chronic Pain Causing Disorders 200
Innovation and New products 200
Market Trends 200
INHALATION DEVICES 201
TABLE 55 GLOBAL MARKET FOR INHALATION DEVICE TECHNOLOGIES BY REGION,
THROUGH 2018 ($ MILLIONS) 202
Market Dynamics 202
Innovation and New Products 203
Trends 203
NEEDLE-FREE INJECTIONS/TRANSDERMAL SYSTEMS 204
TABLE 56 GLOBAL MARKET FOR NEEDLE-FREE INJECTION/TRANSDERMAL SYSTEMS
TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS) 205
Market Dynamics 205
New Product Developments 206
Market Trends 207
TABLE 57 MAJOR DRUGS ADMINISTERED THROUGH TRANSDERMAL DRUG
DELIVERY TECHNIQUES 207
CHAPTER 5 MEDICAL DEVICE TECHNOLOGIES MARKET BY REGION 210
NORTH AMERICA 210
TABLE 58 NORTH AMERICAN MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY
SEGMENT, THROUGH 2018 ($ MILLIONS) 210
EUROPE 210
TABLE 59 EUROPEAN MARKET FOR MEDICAL DEVICES TECHNOLOGIES BY
SEGMENT, THROUGH 2018 ($ MILLIONS) 211
ASIA 211
TABLE 60 ASIA MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY SEGMENT,
THROUGH 2018 ($ MILLIONS) 211
CHINA 212
ROW 212
TABLE 61 ROW MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY SEGMENT,
THROUGH 2018 ($ MILLIONS) 213
CHAPTER 6 COMPETITIVE LANDSCAPE 215
FIGURE 46 COMMON STRATEGIES FOLLOWED BY PLAYERS IN THE MEDICAL DEVICE
TECHNOLOGIES MARKET (%) 215
TABLE 62 PRODUCT LAUNCHES AND APPROVALS IN THE MEDICAL DEVICE
TECHNOLOGIES MARKET (JANUARY 2011 TO FEBRUARY 2014) 216
TABLE 63 MERGERS AND ACQUISITIONS IN THE MEDICAL DEVICE TECHNOLOGIES
MARKET (JANUARY 2011 TO FEBRUARY 2014) 223
TABLE 64 AGREEMENTS/JOINT VENTURES/EXPANSION/DIVESTMENT AND
INVESTMENT IN THE MEDICAL DEVICE TECHNOLOGIES MARKET (JANUARY 2011 TO
FEBRUARY 2014)
229
TABLE 65 CERTIFICATION/REORGANIZATION/RandD FACILITIES/SERVICES AND
SOLUTIONS/OTHERS IN THE MEDICAL DEVICE TECHNOLOGIES MARKET (JANUARY
2011 TO FEBRUARY 2014)
236
TABLE 66 CERTIFICATIONS AND SERVICES IN THE MEDICAL DEVICE
TECHNOLOGIES MARKET (JANUARY 2011 TO FEBRUARY 2014) 240
CHAPTER 7 COMPANY PROFILES 242
3M 242
TABLE 67 3M PRODUCT PORTFOLIO 242
TABLE 68 3M RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014) 242
ABBOTT LABORATORIES 243
TABLE 69 ABBOTT LABORATORIES PRODUCT PORTFOLIO 243
TABLE 70 ABBOTT LABORATORIES RECENT DEVELOPMENTS (JANUARY 2011 TO
FEBRUARY 2014) 244
AGILENT TECHNOLOGIES 244
TABLE 71 AGILENT PRODUCT PORTFOLIO 244
TABLE 72 AGILENT RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014) 245
BAYER 245
TABLE 73 BAYER HEALTHCARE PRODUCT PORTFOLIO 246
TABLE 74 BAYER HEALTHCARE RECENT DEVELOPMENTS (JANUARY 2011 TO
FEBRUARY 2014) 246
BAXTER INTERNATIONAL 246
TABLE 75 BAXTER INTERNATIONAL PRODUCT PORTFOLIO 247
TABLE 76 BAXTER INTERNATIONAL RECENT DEVELOPMENTS (JANUARY 2011 TO
FEBRUARY 2014) 247
BECKTON, DICKINSON AND CO. (BD) 248
TABLE 77 BECKTON, DICKINSON AND COMPANY PRODUCT PORTFOLIO 248
TABLE 78 BECKTON, DICKINSON AND COMPANY RECENT DEVELOPMENTS
(JANUARY 2011 TO FEBRUARY 2014) 248
BOSTON SCIENTIFIC 249
TABLE 79 BOSTON SCIENTIFIC PRODUCT PORTFOLIO 249
TABLE 80 BOSTON SCIENTIFIC RECENT DEVELOPMENTS (JANUARY 2011 TO
FEBRUARY 2014) 250
CARDINAL HEALTH 252
TABLE 81 CARDINAL HEALTH PRODUCT PORTFOLIO 252
TABLE 82 CARDINAL HEALTH RECENT DEVELOPMENTS (JANUARY 2011 TO
FEBRUARY 2014) 252
COVIDIEN 253
TABLE 83 COVIDIEN PRODUCT PORTFOLIO 253
TABLE 84 COVIDIEN RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014) 254
DANAHER 255
TABLE 85 DANAHER PRODUCT PORTFOLIO 256
TABLE 86 DANAHER RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014) 256
DRAGER 257
TABLE 87 DRAGER PRODUCT PORTFOLIO 257
TABLE 88 DRAGER RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014) 258
FRESENIUS 258
TABLE 89 FRESENIUS PRODUCT PORTFOLIO 259
TABLE 90 FRESENIUS RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014) 259
GE HEALTHCARE 260
TABLE 91 GE HEALTHCARE PRODUCT PORTFOLIO 260
TABLE 92 GE HEALTHCARE RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY
2014) 261
GETINGE AB 263
TABLE 93 GETINGE AB PRODUCT PORTFOLIO 263
TABLE 94 GETINGE AB RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY
2014) 264
HOSPIRA 264
TABLE 95 HOSPIRA PRODUCT PORTFOLIO 264
TABLE 96 HOSPIRA RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014) 265
JOHNSON and JOHNSON 266
TABLE 97 JOHNSON and JOHNSON PRODUCT PORTFOLIO 266
TABLE 98 JOHNSON and JOHNSON RECENT DEVELOPMENTS (JANUARY 2011 TO
FEBRUARY 2014) 267
KIMBERLY-CLARK HEALTH CARE 268
TABLE 99 KIMBERLY-CLARK HEALTH CARE PRODUCT PORTFOLIO 269
TABLE 100 KIMBERLY-CLARK HEALTH CARE RECENT DEVELOPMENTS (JANUARY
2011 TO FEBRUARY 2014) 269
MEDTRONIC 270
TABLE 101 MEDTRONIC PRODUCT PORTFOLIO 270
TABLE 102 MEDTRONIC RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY
2014) 271
NOVARTIS 272
TABLE 103 NOVARTIS PRODUCT PORTFOLIO 273
TABLE 104 NOVARTIS RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY
2014) 273
OLYMPUS COPORATION 273
TABLE 105 OLYMPUS CORP. PRODUCT PORTFOLIO 274
TABLE 106 OLYMPUS CORP. RECENT DEVELOPMENTS (JANUARY 2011 TO
FEBRUARY 2014) 275
PALL CORP. 275
TABLE 107 PALL CORP. PRODUCT PORTFOLIO 276
TABLE 108 PALL CORP. RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY
2014) 276
PHILIPS HEALTHCARE 277
TABLE 109 PHILIPS PRODUCT PORTFOLIO 277
TABLE 110 PHILIPS RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014) 278
ROCHE DIAGNOSTICS 280
TABLE 111 ROCHE DIAGNOSTICS PRODUCT PORTFOLIO 280
TABLE 112 ROCHE DIAGNOSTICS RECENT DEVELOPMENTS (JANUARY 2011 TO
FEBRUARY 2014) 281
SAINT JUDE MEDICAL 282
TABLE 113 SAINT JUDE MEDICAL PRODUCT PORTFOLIO 282
TABLE 114 SAINT JUDE MEDICAL RECENT DEVELOPMENTS (JANUARY 2011 TO
FEBRUARY 2014) 282
SIEMENS HEALTHCARE 284
TABLE 115 SIEMENS HEALTHCARE PRODUCT PORTFOLIO 284
TABLE 116 SIEMENS HEALTHCARE RECENT DEVELOPMENTS (JANUARY 2011 TO
FEBRUARY 2014) 285
SMITH and NEPHEW 286
TABLE 117 SMITH and NEPHEW PRODUCT PORTFOLIO 287
TABLE 118 SMITH and NEPHEW RECENT DEVELOPMENTS (JANUARY 2011 TO
FEBRUARY 2014) 287
SMITHS MEDICAL 288
TABLE 119 SMITHS MEDICAL PRODUCT PORTFOLIO 289
TABLE 120 SMITHS MEDICAL RECENT DEVELOPMENTS (JANUARY 2011 TO
FEBRUARY 2014) 289
STRYKER CORP. 290
TABLE 121 STRYKER CORP. PRODUCT PORTFOLIO 291
TABLE 122 STRYKER CORP. RECENT DEVELOPMENTS (2011 TO FEBRUARY 2014) 291
SYNTHES 292
TABLE 123 SYNTHES PRODUCT PORTFOLIO 293
TABLE 124 SYNTHES RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014) 293
TELEFLEX 293
TABLE 125 TELEFLEX PRODUCT PORTFOLIO 294
TABLE 126 TELEFLEX RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014) 294
THERMO FISHER SCIENTIFIC 295
TABLE 127 THERMO FISHER SCIENTIFIC PRODUCT PORTFOLIO 295
TABLE 128 THERMO FISHER SCIENTIFIC RECENT DEVELOPMENTS (JANUARY 2011
TO FEBRUARY 2014) 295
TOSHIBA MEDICAL SYSTEMS CORP. 297
TABLE 129 TOSHIBA MEDICAL SYSTEMS PRODUCT PORTFOLIO 297
TABLE 130 TOSHIBA MEDICAL SYSTEMS RECENT DEVELOPMENTS (JANUARY 2011
TO FEBRUARY 2014) 298
ZIMMER HOLDINGS 298
TABLE 131 ZIMMER HOLDINGS PRODUCT PORTFOLIO 299
TABLE 132 ZIMMER HOLDINGS RECENT DEVELOPMENTS (JANUARY 2011 TO
FEBRUARY 2014) 299
CHAPTER 8 PATENT ANALYSIS 302
FIGURE 47 MEDICAL DEVICE TECHNOLOGIES PATENTS BY REGION, 2011-2014 (%) 302
TABLE 133 LIST OF MEDICAL DEVICE TECHNOLOGIES PATENTS FILED IN THE U.S.
(2011-2014) 303
TABLE 134 LIST OF MEDICAL DEVICE TECHNOLGIES PATENTS FILED IN EUROPE
2011-2014 308
TABLE 135 LIST OF MEDICAL DEVICE TECHNOLOGIES PATENTS FILED IN JAPAN
(2011-2014) 315
DEVICE TECHNOLOGIES PATENTS BY REGION, 2011-2014 (%) 302

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...

2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

  • $ 33500
  • Industry report
  • October 2016
  • by Venture Planning Group

This 33-country survey from VPGMarketResearch.com contains over 900 pages, 380 tables and provides granular data and analysis not available elsewhere. The survey is designed to help current suppliers and ...

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

  • $ 30000
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 28-country survey from VPGMarketResearch.com contains over 820 pages and 418 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.